Evidence map›Paper›PMID 29854491›Full record

ArticleCase reports in gastrointestinal medicine2018

Adverse Effects of Proton Pump Inhibitors on Platelet Count: A Case Report and Review of the Literature.

Subhajit Mukherjee, Tanima Jana, Jen-Jung Pan

Abstract readCase Reports
In one paragraph

Article in Case reports in gastrointestinal medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Proton pump inhibitors induce hemolytic anemia.Journal of family medicine and primary care · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Subhajit MukherjeeDivision of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA.ORCID 0000-0002-6321-9240
Tanima JanaDivision of Gastroenterology, Hepatology and Nutrition, Department of Internal Medicine, The University of Texas Health Science Center, Houston, TX 77030, USA.ORCID 0000-0003-0881-5215
Jen-Jung PanDivision of Gastroenterology and Hepatology, Department of Medicine, University of Arizona College of Medicine, Tucson, AZ 85724, USA.ORCID 0000-0001-5347-3387

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Proton pump inhibitors (PPIs) are the most effective and preferred class of drugs used to treat peptic ulcer disease, gastroesophageal reflux disease, and other diseases associated with increased production of gastric acid. PPIs in general have an excellent long-term safety profile and are well-tolerated. However, studies have shown some adverse reactions (e.g., osteoporosis,

Identifiers

PMID29854491
PMCPMC5952557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.